McKesson Co. (NYSE:MCK) Stock Holdings Boosted by Legacy Private Trust Co.

Legacy Private Trust Co. lifted its position in McKesson Co. (NYSE:MCK) by 1.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,518 shares of the company’s stock after buying an additional 150 shares during the period. Legacy Private Trust Co.’s holdings in McKesson were worth $8,844,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Private Advisor Group LLC increased its holdings in shares of McKesson by 4.2% in the second quarter. Private Advisor Group LLC now owns 11,467 shares of the company’s stock valued at $6,697,000 after buying an additional 462 shares in the last quarter. Los Angeles Capital Management LLC boosted its position in shares of McKesson by 254.0% in the 2nd quarter. Los Angeles Capital Management LLC now owns 2,418 shares of the company’s stock valued at $1,412,000 after purchasing an additional 1,735 shares during the period. PFG Investments LLC purchased a new stake in shares of McKesson in the 2nd quarter valued at approximately $249,000. Prudential PLC boosted its stake in McKesson by 0.4% in the 2nd quarter. Prudential PLC now owns 14,704 shares of the company’s stock worth $8,588,000 after purchasing an additional 52 shares during the period. Finally, Wedbush Securities Inc. grew its position in McKesson by 1.9% during the 2nd quarter. Wedbush Securities Inc. now owns 1,680 shares of the company’s stock worth $981,000 after purchasing an additional 32 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Insider Activity at McKesson

In related news, EVP Leann B. Smith sold 579 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $602.81, for a total value of $349,026.99. Following the completion of the transaction, the executive vice president now directly owns 1,443 shares of the company’s stock, valued at $869,854.83. This trade represents a 28.64 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.11% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

MCK has been the subject of several recent analyst reports. Wells Fargo & Company raised their target price on McKesson from $535.00 to $641.00 and gave the stock an “equal weight” rating in a research report on Friday, December 13th. Morgan Stanley lifted their target price on McKesson from $612.00 to $642.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. Leerink Partners decreased their price target on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a report on Monday, October 7th. Citigroup upped their price objective on shares of McKesson from $630.00 to $713.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Finally, Mizuho initiated coverage on shares of McKesson in a report on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $648.71.

McKesson Price Performance

MCK traded up $4.36 on Wednesday, hitting $589.60. The company had a trading volume of 526,011 shares, compared to its average volume of 619,114. The stock has a market cap of $74.84 billion, a price-to-earnings ratio of 30.53, a price-to-earnings-growth ratio of 1.25 and a beta of 0.49. The company’s fifty day moving average price is $587.85 and its 200 day moving average price is $561.25. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $637.51.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.88 by $0.19. The business had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. McKesson’s quarterly revenue was up 21.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.23 EPS. On average, sell-side analysts forecast that McKesson Co. will post 32.73 EPS for the current year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Monday, December 2nd were given a dividend of $0.71 per share. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.48%. McKesson’s dividend payout ratio is presently 14.71%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.